1 January 2017 in Oxidative Medicine and Cellular Longevity
Natural products with antioxidative activities are widely applied to prevent and treat various oxidative stress related diseases, including ischemic heart disease. However, the cellular and molecular mechanisms of those therapies are still needed to be illustrated. In this study, we characterized the cardioprotective effects of Hongjingtian Injection (HJT), an extensively used botanical drug for treating coronary heart disease. The H/R‐induced profound elevation of oxidative stress was suppressed by HJT. HJT also attenuates oxidative injury by promoting cell viability, intracellular ATP contents, and mitochondrial oxygen consumption. Validation experiments indicated that HJT inhibited H/R‐induced apoptosis and regulated the expression of apoptosis‐associated proteins Bcl‐2 and cleaved caspase3. Interestingly, HJT significantly regulated the expression of autophagy‐related proteins LC3, Beclin, and mTOR as well as ERK and AKT. We provide evidence that the mechanism involves activation of AKT/Beclin‐1, AKT, and ERK/mTOR pathway in cardiomyocyte autophagy. Histological and physiological evaluation revealed that HJT significantly decreased the infarct area of the heart, improved cardiac function, and increased the expression of LC3B in a rat model of coronary occlusion. From the obtained data, we proposed that HJT diminished myocardial oxidative damage through regulating the balance of autophagy and apoptosis and reducing oxidative stress.
13 January 2005 in Cancer Science
Ten primary central nervous system lymphomas (PCNSL, brain lymphomas) were examined for p14 gene exon 1β deletion, mutation and methylation by Southern blot analysis, nucleotide analysis of polymerase chain reaction clones and Southern blot‐based methylation assay. In Southern blot analysis, from the signal densities of the hybridized bands and their similarities to those of exons 2 and 3 in our previous quantitative study, we found that exon 1β was homozygously deleted in four cases, hemizygously deleted in five cases and not deleted in one case. Thus, the same deletion patterns covered the entire p14 gene for all cases except for one case, which suggested the hemizygous deletion of exons 1β and 2 and homozygous deletion of exon 3. In addition, although exon 1β mutation is rare in various tumors, we detected a missense mutation (L50R) in one case with a hemizygous deletion. Methylation of the 5′CpG island of the p14 gene was not suggested for any case without homozygous deletion. Our observation of frequent p14 gene abnormalities (90%) and inactivation (40–60%) was in striking contrast to the same pathological subtype of systemic lymphoma in which p14 gene abnormalities and inactivation were infrequent, suggesting a difference in carcinogenesis between PCNSL and systemic lymphoma. (Cancer Sci 2005; 96: 38 –41)
8 November 2026 in Records of Natural Products
Niuhuang Shangqing Capsule (NHSQC) is a classical heat-pattern-related multi-herb traditional Chinese medicine formula. This study investigated its therapeutic effects and mechanisms in a mouse model of internal excess-heat pattern constipation using integrated metabolomics and gut microbiota multi-omics. Ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) putatively annotated 201 compounds in NHSQC. A constipation model was established by combined administration of a hot-nature herbal extract and loperamide. NHSQC treatment significantly shortened the time to first black stool, increased fecal water content, and enhanced small intestinal transit rate. It upregulated colonic tight junction protein expression, improved serum gastrointestinal hormone profiles, increased goblet cell numbers, and reduced levels of inflammatory cytokines (IL-1, TNF-, IL-6). Furthermore, NHSQC modulated gut microbiota composition, altered fecal metabolite profiles, and preliminarily indicated the involvement of the FoxO signaling pathway in its protective effects. These findings provide pre-clinical evidence that NHSQC alleviates internal excess-heat pattern constipation through a multi-dimensional regulatory network involving multiple components, molecular targets, gut microbiota, and metabolic signaling including the FoxO pathway to restore intestinal function.
28 October 2026 in Journal of Ethnopharmacology
23 September 2026 in SSRN Electronic Journal
Ethnopharmacological relevance: Chang-Yan-Ning Granules (CYN) is a traditional Chinese herbal formula widely used in the clinical management of ulcerative colitis (UC). However, its molecular mechanisms of action, particularly with respect to intestinal barrier protection, remain incompletely understood. Aim of the study: This study aimed to systematically investigate the effects and underlying mechanisms of CYN in colitis, with a focus on identifying its functional molecular targets and bioactive constituents. Methods: A dextran sulfate sodium (DSS)-induced acute colitis mouse model was established to evaluate the in vivo efficacy of CYN. Integrated approaches combining RNA sequencing, network pharmacology prediction, chemical profiling, and public database mining were employed to predict candidate targets. Multi-scale in vitro and vivo validation was performed using THP-1 co-cultured intestinal epithelial cells, mouse colonic organoids, and a zebrafish model of UC. Somatostatin receptor 1 (SSTR1) functional validation was conducted via siRNA-mediated knockdown. Results: CYN treatment reduced disease activity index (DAI) scores, partially restored colonic length, preserved colonic crypt architecture, and increased occludin expression in DSS-treated mice. Across the cell co-culture and colonic organoid models, CYN suppressed inflammatory responses and preserved epithelial barrier integrity, as indicated by reduced TNF-α and IL-6 levels and improved expression or junctional distribution of occludin and ZO-1. In zebrafish, CYN reduced intestinal neutrophil accumulation and ameliorated model-associated alterations in goblet cells and intestinal morphology .Transcriptomic and network pharmacology analyses revealed enrichment of inflammation-related pathways and identified SSTR1 as a candidate target. Rutin and rosmarinic acid (RA), two blood-absorbed constituents of CYN, showed barrier-protective and anti-inflammatory activity. DARTS and molecular docking results supported potential interactions between rutin or RA and SSTR1. The effects of CYN and both constituents were markedly attenuated after SSTR1 knockdown. Conclusion: CYN alleviates experimental colitis and preserves intestinal barrier integrity. Rutin and RA were identified as blood-absorbed bioactive constituents that contribute to the barrier-protective and anti-inflammatory effects of CYN through an SSTR1-dependent mechanism. The complementary evidence from functional knockdown, DARTS, and molecular docking supported SSTR1 as a key functional mediator of CYN. These findings provide a mechanistic basis for the therapeutic effects of CYN in UC and highlight the SSTR1-associated pathway as a potential strategy for intestinal barrier protection.